Selected aspects of genetic counselling for BRCA1 mutation carriers

被引:0
|
作者
Jacek Gronwald
机构
[1] Department of Genetics and Pathology,International Hereditary Cancer Center
来源
Hereditary Cancer in Clinical Practice | / 5卷
关键词
breast cancer; ovarian cancer; risk factors;
D O I
暂无
中图分类号
学科分类号
摘要
This work consists of six parts based on seven manuscripts dealing with some aspects of genetic counselling for BRCA1 mutation carriers. It was demonstrated that the risk of breast and ovarian cancer in first-degree relatives of BRCA1 mutation carriers depends on the type of mutation and is higher in the younger generation. It was also shown that risk of breast cancer, but not of ovarian cancer, is related to cancer type of the proband. These factors should be taken into account when assessing risk of breast and ovarian cancer in relatives of BRCA1 mutation carriers. It was observed that longer breast-feeding, physical activities delaying menarche, preventive oophorectomy, administration of tamoxifen to patients with intact genital tract, and use of contraceptives reduce the risk of breast and ovarian cancer. All these possibilities should be presented to BRCA1 mutation carriers within the framework of cancer risk reduction options. It was also observed that there may be some preference in transmission of the mutant allele to female offspring of BRCA1 founder mutation carriers. Environmental factors appear also to interfere with transmission. The male to female ratio in offspring of BRCA1 mutation carriers is the same as for the general population. As for the consequences of simplified two-stage genetic counselling, the first psychological reaction of a female to the fact that she is a carrier of the BRCA1 mutation is negative. However, understanding that the risk of cancer is high persuades the woman to embrace preventive options. 98% of BRCA1 mutation carriers disclosed during population screening initiated and promoted by the media are convinced of the value of genetic testing. Simplified two-stage genetic counselling appears to be a useful approach promoting increased turnout for BRCA1 mutation testing.
引用
收藏
相关论文
共 50 条
  • [31] Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific
    Chehade, Rania
    Pettapiece-Phillips, Rachael
    Salmena, Leonardo
    Kotlyar, Max
    Jurisica, Igor
    Narod, Steven A.
    Akbari, Mohammad R.
    Kotsopoulos, Joanne
    BREAST CANCER RESEARCH, 2016, 18
  • [32] A survey of preventive measures among BRCA1 mutation carriers from Poland
    Gronwald, J.
    Byrski, T.
    Huzarski, T.
    Cybulski, C.
    Stawicka, M.
    Szwiec, M.
    Debniak, T.
    Tulman, A.
    Sun, P.
    Oszurek, O.
    Lubinski, J.
    Narod, S. A.
    CLINICAL GENETICS, 2007, 71 (02) : 153 - 157
  • [33] Impact of Prophylactic Mastectomy in BRCA1/2 Mutation Carriers
    Rhiem, Kerstin
    Schmutzler, Rita
    BREAST CARE, 2014, 9 (06) : 385 - 389
  • [34] Cardiovascular risk of BRCA1/2 mutation carriers: A review
    van Westerop, L. L. M.
    Jong, M. Arts-de
    Hoogerbrugge, N.
    de Hullu, J. A.
    Maas, A. H. E. M.
    MATURITAS, 2016, 91 : 135 - 139
  • [35] DNA repair capacity is impaired in healthy BRCA1 heterozygous mutation carriers
    Vaclova, Tereza
    Gomez-Lopez, Gonzalo
    Setien, Fernando
    Garcia Bueno, Jose Maria
    Antonio Macias, Jose
    Barroso, Alicia
    Urioste, Miguel
    Esteller, Manel
    Benitez, Javier
    Osorio, Ana
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (02) : 271 - 282
  • [36] Selenium and genotypes as marker of risk in BRCA1 mutation carriers
    K Jaworska
    A Jakubowska
    T Huzarski
    K Durda
    P Serrano-Fernandez
    G Sukiennicki
    M Muszyńska
    T Byrski
    J Gronwald
    S Gupta
    J J Lubiński
    Hereditary Cancer in Clinical Practice, 10 (Suppl 1)
  • [37] Changes in the expression of plasma proteins associated with thrombosis in BRCA1 mutation carriers
    Custodio, Ana
    Lopez-Farre, Antonio J.
    Zamorano-Leon, Jose J.
    Mateos-Caceres, Petra J.
    Macaya, Carlos
    Caldes, Trinidad
    de la Hoya, Miguel
    Olivera, Elena
    Puente, Javier
    Diaz-Rubio, Eduardo
    Perez-Segura, Pedro
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (05) : 867 - 875
  • [38] Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers
    Lee, Y. C.
    Milne, R. L.
    Lheureux, S.
    Friedlander, M.
    McLachlan, S. A.
    Martin, K. L.
    Bernardini, M. Q.
    Smith, C.
    Picken, S.
    Nesci, S.
    Hopper, J. L.
    Phillips, K. A.
    EUROPEAN JOURNAL OF CANCER, 2017, 84 : 114 - 120
  • [39] Nonsurgical Prevention Strategies in BRCA1 and BRCA2 Mutation Carriers
    Singer, Christian F.
    BREAST CARE, 2021, 16 (02) : 144 - 148
  • [40] Survival in Norwegian BRCA1 mutation carriers with breast cancer
    Anne Irene Hagen
    Steinar Tretli
    Lovise Mæhle
    Jaran Apold
    Nina Vedå
    Pål Møller
    Hereditary Cancer in Clinical Practice, 7